PortfoliosLab logo
ABCL vs. PI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ABCL and PI is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ABCL vs. PI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbCellera Biologics Inc. (ABCL) and Impinj, Inc. (PI). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

ABCL:

59.42%

PI:

28.60%

Max Drawdown

ABCL:

-8.22%

PI:

-1.98%

Current Drawdown

ABCL:

-7.31%

PI:

0.00%

Fundamentals

Market Cap

ABCL:

$605.80M

PI:

$2.90B

EPS

ABCL:

-$0.55

PI:

-$0.06

PS Ratio

ABCL:

21.02

PI:

7.97

PB Ratio

ABCL:

0.57

PI:

17.63

Total Revenue (TTM)

ABCL:

$18.88M

PI:

$363.54M

Gross Profit (TTM)

ABCL:

-$71.35M

PI:

$187.49M

EBITDA (TTM)

ABCL:

-$164.12M

PI:

$14.54M

Returns By Period


ABCL

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

PI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ABCL vs. PI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABCL
The Risk-Adjusted Performance Rank of ABCL is 1313
Overall Rank
The Sharpe Ratio Rank of ABCL is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of ABCL is 1212
Sortino Ratio Rank
The Omega Ratio Rank of ABCL is 1515
Omega Ratio Rank
The Calmar Ratio Rank of ABCL is 1919
Calmar Ratio Rank
The Martin Ratio Rank of ABCL is 66
Martin Ratio Rank

PI
The Risk-Adjusted Performance Rank of PI is 2121
Overall Rank
The Sharpe Ratio Rank of PI is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of PI is 2121
Sortino Ratio Rank
The Omega Ratio Rank of PI is 2121
Omega Ratio Rank
The Calmar Ratio Rank of PI is 1717
Calmar Ratio Rank
The Martin Ratio Rank of PI is 2424
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ABCL vs. PI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and Impinj, Inc. (PI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

ABCL vs. PI - Dividend Comparison

Neither ABCL nor PI has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ABCL vs. PI - Drawdown Comparison

The maximum ABCL drawdown since its inception was -8.22%, which is greater than PI's maximum drawdown of -1.98%. Use the drawdown chart below to compare losses from any high point for ABCL and PI. For additional features, visit the drawdowns tool.


Loading data...

Volatility

ABCL vs. PI - Volatility Comparison


Loading data...

Financials

ABCL vs. PI - Financials Comparison

This section allows you to compare key financial metrics between AbCellera Biologics Inc. and Impinj, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00M20212022202320242025
5.05M
74.28M
(ABCL) Total Revenue
(PI) Total Revenue
Values in USD except per share items